Welcome!

News Feed Item

Lumbar Spinal Stenosis Global Clinical Trials Review, H2, 2014

NEW YORK, Aug. 5, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Lumbar Spinal Stenosis Global Clinical Trials Review, H2, 2014

http://www.reportlinker.com/p02256136/Lumbar-Spinal-Stenosis-Global-Clinical-Trials-Review-H2-2014.html

Lumbar Spinal Stenosis Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Lumbar Spinal Stenosis Global Clinical Trials Review, H2, 2014" provides data on the Lumbar Spinal Stenosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Lumbar Spinal Stenosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Lumbar Spinal Stenosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Lumbar Spinal Stenosis 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11

Top Countries Contributing to Clinical Trials in Central and South America 12
Clinical Trials by G7 Countries: Proportion of Lumbar Spinal Stenosis to Central Nervous System Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Lumbar Spinal Stenosis to Central Nervous System Clinical Trials 16
Clinical Trials by Phase in E7 Countries 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Clinical Trials by End Point Status 21
Unaccomplished Trials of Lumbar Spinal Stenosis 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Lumbar Spinal Stenosis Therapeutics Clinical Trials 26
Prominent Drugs 27
Clinical Trial Profiles 28

Clinical Trial Overview of Top Companies 28
Sucampo Pharmaceuticals, Inc. 28
Clinical Trial Overview of Sucampo Pharmaceuticals, Inc. 28
United Therapeutics Corporation 29
Clinical Trial Overview of United Therapeutics Corporation 29
Mesoblast Limited 30
Clinical Trial Overview of Mesoblast Limited 30
KT&G Corporation 31
Clinical Trial Overview of KT&G Corporation 31
Kaken Pharmaceutical Co., Ltd. 32
Clinical Trial Overview of Kaken Pharmaceutical Co., Ltd. 32
Clinical Trial Overview of Top Institutes / Government 33
Keio University 33
Clinical Trial Overview of Keio University 33
Hamamatsu University School of Medicine 34
Clinical Trial Overview of Hamamatsu University School of Medicine 34
National University Of Health Sciences 35
Clinical Trial Overview of National University Of Health Sciences 35

University of Manitoba 36
Clinical Trial Overview of University of Manitoba 36
Asan Medical Center 37
Clinical Trial Overview of Asan Medical Center 37
Kobe University 38
Clinical Trial Overview of Kobe University 38
Yonsei University 39
Clinical Trial Overview of Yonsei University 39
Ohio State University 40
Clinical Trial Overview of Ohio State University 40
Leiden University Medical Center 41
Clinical Trial Overview of Leiden University Medical Center 41
Emory University 42
Clinical Trial Overview of Emory University 42
Five Key Clinical Profiles 43
Appendix 65
Abbreviations 65
Definitions 65
Research Methodology 66
Secondary Research 66
About GlobalData 67
Contact Us 67
Disclaimer 67
Source 67

List of Tables

Lumbar Spinal Stenosis Therapeutics, Global, Clinical Trials by Region, 2014* 6
Lumbar Spinal Stenosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Lumbar Spinal Stenosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Lumbar Spinal Stenosis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Lumbar Spinal Stenosis Therapeutics Clinical Trials, Europe, Top Countries, 2014* 10
Lumbar Spinal Stenosis Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Lumbar Spinal Stenosis Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 12
Proportion of Lumbar Spinal Stenosis to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 13
Lumbar Spinal Stenosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Lumbar Spinal Stenosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Lumbar Spinal Stenosis to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 16
Lumbar Spinal Stenosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 17
Lumbar Spinal Stenosis Therapeutics, Global, Clinical Trials by Phase, 2014* 18

Lumbar Spinal Stenosis Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 19
Lumbar Spinal Stenosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 20
Lumbar Spinal Stenosis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 21
Lumbar Spinal Stenosis Therapeutics, Global, Terminated Clinical Trials, 2014* 22
Lumbar Spinal Stenosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Lumbar Spinal Stenosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 24
Lumbar Spinal Stenosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Lumbar Spinal Stenosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26
Lumbar Spinal Stenosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
Lumbar Spinal Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sucampo Pharmaceuticals, Inc., 2014* 28
Lumbar Spinal Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by United Therapeutics Corporation, 2014* 29

Lumbar Spinal Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mesoblast Limited, 2014* 30
Lumbar Spinal Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by KT&G Corporation, 2014* 31
Lumbar Spinal Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Kaken Pharmaceutical Co., Ltd., 2014* 32
Lumbar Spinal Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Keio University, 2014* 33
Lumbar Spinal Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hamamatsu University School of Medicine, 2014* 34
Lumbar Spinal Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National University Of Health Sciences, 2014* 35
Lumbar Spinal Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Manitoba, 2014* 36
Lumbar Spinal Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2014* 37
Lumbar Spinal Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Kobe University, 2014* 38
Lumbar Spinal Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Yonsei University, 2014* 39
Lumbar Spinal Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ohio State University, 2014* 40
Lumbar Spinal Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2014* 41
Lumbar Spinal Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2014* 42

List of Figures

Lumbar Spinal Stenosis Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Lumbar Spinal Stenosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Lumbar Spinal Stenosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Lumbar Spinal Stenosis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 9
Lumbar Spinal Stenosis Therapeutics Clinical Trials, Europe, Top Countries (%), 2014* 10
Lumbar Spinal Stenosis Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Proportion of Lumbar Spinal Stenosis to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 13
Lumbar Spinal Stenosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Lumbar Spinal Stenosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Lumbar Spinal Stenosis to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 16
Lumbar Spinal Stenosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 17
Lumbar Spinal Stenosis Therapeutics, Global, Clinical Trials by Phase (%), 2014* 18
Lumbar Spinal Stenosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 19
Lumbar Spinal Stenosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 20
Lumbar Spinal Stenosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Lumbar Spinal Stenosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 24
Lumbar Spinal Stenosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Lumbar Spinal Stenosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26
Lumbar Spinal Stenosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
GlobalData Methodology 66

To order this report: Lumbar Spinal Stenosis Global Clinical Trials Review, H2, 2014
http://www.reportlinker.com/p02256136/Lumbar-Spinal-Stenosis-Global-Clinical-Trials-Review-H2-2014.html

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
DevOps at Cloud Expo, taking place Nov 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA, is co-located with 19th Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The widespread success of cloud computing is driving the DevOps revolution in enterprise IT. Now as never before, development teams must communicate and collaborate in a dynamic, 24/7/365 environment. There is no time to wait for long dev...
Amazon has gradually rolled out parts of its IoT offerings in the last year, but these are just the tip of the iceberg. In addition to optimizing their back-end AWS offerings, Amazon is laying the ground work to be a major force in IoT – especially in the connected home and office. Amazon is extending its reach by building on its dominant Cloud IoT platform, its Dash Button strategy, recently announced Replenishment Services, the Echo/Alexa voice recognition control platform, the 6-7 strategic...
19th Cloud Expo, taking place November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA, will feature technical sessions from a rock star conference faculty and the leading industry players in the world. Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud strategy. Meanwhile, 94% of enterpri...
Using new techniques of information modeling, indexing, and processing, new cloud-based systems can support cloud-based workloads previously not possible for high-throughput insurance, banking, and case-based applications. In his session at 18th Cloud Expo, John Newton, CTO, Founder and Chairman of Alfresco, described how to scale cloud-based content management repositories to store, manage, and retrieve billions of documents and related information with fast and linear scalability. He addres...
Akana has announced the availability of version 8 of its API Management solution. The Akana Platform provides an end-to-end API Management solution for designing, implementing, securing, managing, monitoring, and publishing APIs. It is available as a SaaS platform, on-premises, and as a hybrid deployment. Version 8 introduces a lot of new functionality, all aimed at offering customers the richest API Management capabilities in a way that is easier than ever for API and app developers to use.
Personalization has long been the holy grail of marketing. Simply stated, communicate the most relevant offer to the right person and you will increase sales. To achieve this, you must understand the individual. Consequently, digital marketers developed many ways to gather and leverage customer information to deliver targeted experiences. In his session at @ThingsExpo, Lou Casal, Founder and Principal Consultant at Practicala, discussed how the Internet of Things (IoT) has accelerated our abil...
Kubernetes, Docker and containers are changing the world, and how companies are deploying their software and running their infrastructure. With the shift in how applications are built and deployed, new challenges must be solved. In his session at @DevOpsSummit at19th Cloud Expo, Sebastian Scheele, co-founder of Loodse, will discuss the implications of containerized applications/infrastructures and their impact on the enterprise. In a real world example based on Kubernetes, he will show how to ...
With so much going on in this space you could be forgiven for thinking you were always working with yesterday’s technologies. So much change, so quickly. What do you do if you have to build a solution from the ground up that is expected to live in the field for at least 5-10 years? This is the challenge we faced when we looked to refresh our existing 10-year-old custom hardware stack to measure the fullness of trash cans and compactors.
SYS-CON Events announced today that Isomorphic Software will exhibit at DevOps Summit at 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. Isomorphic Software provides the SmartClient HTML5/AJAX platform, the most advanced technology for building rich, cutting-edge enterprise web applications for desktop and mobile. SmartClient combines the productivity and performance of traditional desktop software with the simp...
The emerging Internet of Everything creates tremendous new opportunities for customer engagement and business model innovation. However, enterprises must overcome a number of critical challenges to bring these new solutions to market. In his session at @ThingsExpo, Michael Martin, CTO/CIO at nfrastructure, outlined these key challenges and recommended approaches for overcoming them to achieve speed and agility in the design, development and implementation of Internet of Everything solutions wi...
Cloud computing is being adopted in one form or another by 94% of enterprises today. Tens of billions of new devices are being connected to The Internet of Things. And Big Data is driving this bus. An exponential increase is expected in the amount of information being processed, managed, analyzed, and acted upon by enterprise IT. This amazing is not part of some distant future - it is happening today. One report shows a 650% increase in enterprise data by 2020. Other estimates are even higher....
I wanted to gather all of my Internet of Things (IOT) blogs into a single blog (that I could later use with my University of San Francisco (USF) Big Data “MBA” course). However as I started to pull these blogs together, I realized that my IOT discussion lacked a vision; it lacked an end point towards which an organization could drive their IOT envisioning, proof of value, app dev, data engineering and data science efforts. And I think that the IOT end point is really quite simple…
Internet of @ThingsExpo, taking place November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA, is co-located with 19th Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The Internet of Things (IoT) is the most profound change in personal and enterprise IT since the creation of the Worldwide Web more than 20 years ago. All major researchers estimate there will be tens of billions devices - comp...
Qosmos has announced new milestones in the detection of encrypted traffic and in protocol signature coverage. Qosmos latest software can accurately classify traffic encrypted with SSL/TLS (e.g., Google, Facebook, WhatsApp), P2P traffic (e.g., BitTorrent, MuTorrent, Vuze), and Skype, while preserving the privacy of communication content. These new classification techniques mean that traffic optimization, policy enforcement, and user experience are largely unaffected by encryption. In respect wit...
"My role is working with customers, helping them go through this digital transformation. I spend a lot of time talking to banks, big industries, manufacturers working through how they are integrating and transforming their IT platforms and moving them forward," explained William Morrish, General Manager Product Sales at Interoute, in this SYS-CON.tv interview at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York City, NY.